Lv6
3050 积分 2023-03-05 加入
SHR-A2102, a nectin-4 directed antibody–drug conjugate, in patients with pretreated advanced solid tumours: a multicentre, single-arm, phase 1 trial
5天前
已完结
Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
19天前
已完结
Eplontersen for Transthyretin Amyloid Cardiomyopathy
19天前
已完结
SHR-A2102, a nectin-4 directed antibody–drug conjugate, in patients with pretreated advanced solid tumours: a multicentre, single-arm, phase 1 trial
20天前
已完结
APASL_2026_Istanbul
21天前
已完结
Impact of Upadacitinib on Cardiovascular Events and Lipid Values in Older Inflammatory Bowel Disease Patients With Baseline Cardiovascular Risk
28天前
已关闭
Beyond the bowel: three rare complications of upadacitinib therapy in inflammatory bowel disease
28天前
已完结
Off-label upadacitinib 60 mg daily in the rescue of refractory ulcerative colitis: an open-labeled cohort study
28天前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
1个月前
已完结
Danvatirsen plus pembrolizumab versus pembrolizumab for recurrent and/or metastatic head and neck squamous cell carcinoma (PEMDA-HN): a randomized, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
